Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
AstraZeneca licenses respiratory drug to Insmed
Thursday, October 06, 2016Drugmaker Insmed Inc said on Wednesday it had bought the rights to an experimental earlystage respiratory drug from Britains AstraZeneca Plc in a deal worth million AstraZeneca will get million in upfront fees and million in various milestone pay...
Novartis reshapes research, closes some Swiss, Chinese units
Thursday, October 06, 2016Novartis is closing some of its research operations in Switzerland and China and cutting jobs part of the Swiss drug makers effort to centralize control over its drug discovery programs and contain costs Novartis which employs globally is also rel...
U.S. government health plans spent over $1 billion on EpiPens over five years
Thursday, October 06, 2016US government health plans spent more than billion on Mylan NVs EpiPen emergency allergic reaction treatment between and according to figures released by the Centers for Medicare and Medicaid Services on Wednesday Mylan is under scrutiny for rais...
Intas Pharmaceuticals acquires the generics business of Actavis in the UK & Ireland
Thursday, October 06, 2016Intas Pharmaceuticals Ltd through its wholly owned subsidiary Accord Healthcare Ltd announced today that it has entered into definitive agreements to acquire Actavis UK Ltd Actavis Ireland Ltd Actavis UK Ireland from Teva Pharmaceutical Industries...
Sanofi's dengue vaccine approved in 11 countries
Wednesday, October 05, 2016Sanofi Pasteur Sanofis vaccines unit said on Tuesday that its dengue vaccine Dengvaxia had received market approval in eleven countries To date the vaccine has been approved in Mexico the Philippines Brazil El Salvador Costa Rica Paraguay Guatemala...
Sarepta partners with UK's Summit on Duchenne drugs
Wednesday, October 05, 2016Sarepta Therapeutics Inc said it secured the European rights to Summit Therapeutics Plcs experimental Duchenne muscular dystrophy DMD drug as it looks to build on its lead in treating the fatal musclewasting disease Summits shares doubled to pence...
Roche gets boost from FDA in bid to expand uses for Actemra
Wednesday, October 05, 2016The US Food and Drug Administration has granted breakthrough status to Roches rheumatoid arthritis medication Actemra for giant cell arteritis the Swiss drugmaker said a step which could help it broaden applications for the medicine Giant cell arter...
Aralez to Acquire U.S. Rights From AstraZeneca to Beta Blocker Toprol-XL®
Wednesday, October 05, 2016Aralez Pharmaceuticals Inc a global specialty pharmaceutical company today announced it will acquire the US rights to ToprolXL metoprolol succinate and its Authorized Generic AG pursuant to an agreement entered into between AstraZeneca and Aralez Pha...
Vivus and Metuchen Pharmaceuticals announce license agreement for commercial rights to Stendra
Tuesday, October 04, 2016VIVUS Inc says additionally Metuchen will be responsible for royalties due to Mitsubishi Tanabe Pharma corporation based on net sales VIVUS and Metuchen Pharmaceuticals announce license agreement for commercial rights to Stendra VIVUSSigned commerc...
AstraZeneca licenses inflammatory disease candidate to Allergan
Tuesday, October 04, 2016Britains AstraZeneca said it had licensed a potential medicine for inflammatory diseases to Allergan for an upfront payment of million and potential additional payments of up to billion AstraZeneca said the drug developed by its global biologics r...
